Suppr超能文献

慢性酒精摄入破坏了大鼠的胆固醇稳态:肝脏中低密度脂蛋白受体下调和胆固醇生物合成途径增强。

Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver.

机构信息

Department of Human Nutrition, University of Illinois at Chicago, Illinois 60612, USA.

出版信息

Alcohol Clin Exp Res. 2010 Mar 1;34(3):471-8. doi: 10.1111/j.1530-0277.2009.01111.x. Epub 2009 Dec 18.

Abstract

BACKGROUND

Chronic alcohol consumption causes alcoholic liver disease, which is associated, or initiated, with dysregulated lipid metabolism. Very recent evidence suggested that dysregulated cholesterol metabolism plays an important role in the pathogenesis of alcoholic fatty liver diseases, however, the effects of chronic alcohol exposure on cholesterol homeostasis have not been well studied and underlying mechanisms behind are still elusive.

METHODS

Male Sprague-Dawley rats weighing 250 +/- 5.5 g (mean +/- SEM) divided into 2 groups (8 rats per group) and pair-fed with liquid diets containing (in percent of energy intake) 18% protein, 35% fat, 12% carbohydrate, and 35% either ethanol (ethanol diet) or an isocaloric maltose-dextrin mixture (control diet), according to Lieber and De Carli, for 4 weeks.

RESULTS

Long-term excessive alcohol feeding to rats caused fatty liver and liver injury, which was associated with disrupted cholesterol homeostasis, characterized by increased hepatic cholesterol levels and hypercholesterolemia. Hepatic cholesterol increases were concomitant with constantly activated sterol regulatory element-binding protein-2 (SREBP-2) in the liver and increased expression of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, a rate-limiting enzyme for cholesterol de novo synthesis, indicating enhanced cholesterol biosynthesis. Alcohol-induced hypercholesterolemia was accompanied by decreased LDL receptor (LDLr) levels in the liver. Further investigations revealed that chronic alcohol exposure increased hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) contents to down-regulate LDLr via a post-translational mechanism. Moreover, alcohol feeding suppressed extracellular signal-regulated kinase (ERK) activation in the liver. In vitro studies showed that inhibition of ERK activation was associated with decreased LDLr expression in HepG2 cells.

CONCLUSIONS

Our study provides the first evidence that both increased PCSK9 expression and suppressed ERK activation in the liver contributes to alcohol-induced hypercholesterolemia in rats.

摘要

背景

慢性酒精摄入会导致酒精性肝病,而后者与脂质代谢失调有关,或由其引发。最近的证据表明,胆固醇代谢失调在酒精性脂肪肝疾病的发病机制中起着重要作用,然而,慢性酒精暴露对胆固醇稳态的影响尚未得到很好的研究,其潜在机制仍不清楚。

方法

雄性 Sprague-Dawley 大鼠体重 250 ± 5.5 g(平均值 ± SEM),分为 2 组(每组 8 只大鼠),并根据 Lieber 和 De Carli 的方法,用含有(占能量摄入的百分比)18%蛋白质、35%脂肪、12%碳水化合物和 35%乙醇(乙醇饮食)或等热量麦芽糊精混合物(对照饮食)的液体饮食进行喂养 4 周。

结果

长期过量饮酒会导致大鼠脂肪肝和肝损伤,这与胆固醇稳态失调有关,其特征为肝胆固醇水平升高和高胆固醇血症。肝胆固醇的增加与肝中固醇调节元件结合蛋白-2(SREBP-2)的持续激活以及 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶的表达增加有关,HMG-CoA 还原酶是胆固醇从头合成的限速酶,表明胆固醇生物合成增强。酒精引起的高胆固醇血症伴随着肝内 LDL 受体(LDLr)水平的降低。进一步的研究表明,慢性酒精暴露会增加肝前蛋白转化酶枯草杆菌蛋白酶/kexin 9 型(PCSK9)的含量,通过翻译后机制下调 LDLr。此外,酒精喂养抑制了肝外信号调节激酶(ERK)的激活。体外研究表明,ERK 激活的抑制与 HepG2 细胞中 LDLr 表达的降低有关。

结论

我们的研究首次提供了证据表明,肝脏中 PCSK9 表达的增加和 ERK 激活的抑制都有助于大鼠酒精性高胆固醇血症的发生。

相似文献

3
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
6
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.
Exp Mol Pathol. 2012 Aug;93(1):26-34. doi: 10.1016/j.yexmp.2012.03.006. Epub 2012 Mar 16.
7
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease.
Sci Rep. 2019 Nov 20;9(1):17167. doi: 10.1038/s41598-019-53603-6.
8
Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.
Biomed Pharmacother. 2021 Jan;133:110802. doi: 10.1016/j.biopha.2020.110802. Epub 2020 Nov 14.
9
Synergic hypocholesterolaemic effect of n-3 PUFA and oestrogen by modulation of hepatic cholesterol metabolism in female rats.
Br J Nutr. 2015 Dec 14;114(11):1766-73. doi: 10.1017/S0007114515003517. Epub 2015 Sep 21.
10
Chronic-binge ethanol feeding aggravates systemic dyslipidemia in mice, thereby accelerating hepatic fibrosis.
Front Endocrinol (Lausanne). 2023 Jul 25;14:1148827. doi: 10.3389/fendo.2023.1148827. eCollection 2023.

引用本文的文献

1
Fertility-enhancing effects of oil on reproductive functions of male rats: A two-generation study.
Avicenna J Phytomed. 2025 Jan-Feb;15(1):816-837. doi: 10.22038/AJP.2024.24590.
2
Hepatoprotective Effect of Mycelium Powder on Alcohol-Induced Liver Damage.
Nutrients. 2024 Oct 8;16(19):3406. doi: 10.3390/nu16193406.
4
Enlarged perivascular spaces in alcohol-related brain damage induced by dyslipidemia.
J Cereb Blood Flow Metab. 2024 Oct;44(10):1867-1880. doi: 10.1177/0271678X241251570. Epub 2024 May 3.
5
Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease.
Int J Mol Sci. 2023 Dec 21;25(1):150. doi: 10.3390/ijms25010150.
6
Chronic-binge ethanol feeding aggravates systemic dyslipidemia in mice, thereby accelerating hepatic fibrosis.
Front Endocrinol (Lausanne). 2023 Jul 25;14:1148827. doi: 10.3389/fendo.2023.1148827. eCollection 2023.
8
Dietary cholesterol in alcohol-associated liver disease.
Immunometabolism (Cobham). 2023 May 3;5(2):e00026. doi: 10.1097/IN9.0000000000000026. eCollection 2023 Apr.
10

本文引用的文献

1
The LDL receptor.
Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):431-8. doi: 10.1161/ATVBAHA.108.179564.
2
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.
J Hepatol. 2009 Apr;50(4):789-96. doi: 10.1016/j.jhep.2008.12.016. Epub 2009 Jan 14.
3
Betaine administration corrects ethanol-induced defective VLDL secretion.
Mol Cell Biochem. 2009 Jul;327(1-2):75-8. doi: 10.1007/s11010-009-0044-2. Epub 2009 Feb 15.
4
PCSK9 as a therapeutic target of dyslipidemia.
Expert Opin Ther Targets. 2009 Jan;13(1):19-28. doi: 10.1517/14728220802600715.
6
Cholesterol and sphingolipids in alcohol-induced liver injury.
J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S9-15. doi: 10.1111/j.1440-1746.2007.05280.x.
7
PCSK9: an enigmatic protease.
Biochim Biophys Acta. 2008 Apr;1781(4):184-91. doi: 10.1016/j.bbalip.2008.01.003. Epub 2008 Feb 2.
8
Alcohol-induced steatosis in liver cells.
World J Gastroenterol. 2007 Oct 7;13(37):4974-8. doi: 10.3748/wjg.v13.i37.4974.
9
Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.
Biochem Pharmacol. 2007 Feb 15;73(4):574-85. doi: 10.1016/j.bcp.2006.10.027. Epub 2006 Nov 10.
10
Cholesterol sensing, trafficking, and esterification.
Annu Rev Cell Dev Biol. 2006;22:129-57. doi: 10.1146/annurev.cellbio.22.010305.104656.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验